TNXP logo

TNXP

Profile

Full Name

Tonix Pharmaceuticals Holding Corp.

Ticker Symbol

TNXP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 10, 2012

Indexes

Not included

Website

http://www.tonixpharma.com

Employees

81

Key Details

Price

$15.71(-0.95%)

Market cap

$101.09M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.09M(+29.94% YoY)

Annual EPS

-$176.60(+98.80% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$15.71
TNXP price is $15.71

30-Day Relative Volume

0.21
TNXP 30-day relative volume is 0.21

Price Performance

Price Most recent change

-0.95%
TNXP price was down -0.95% on Apr 17, 2025

Price YTD change

-52.39%
TNXP price is down -52.39% since January 1st

Price 1-year change

-96.93%
TNXP price is down -96.93% year-on-year

Price 3-year change

-99.99%
TNXP price is down -99.99% over the past 3 years

Price Range

Price All-time high

$19200000000.00
TNXP price is currently -100.00% below its historical high of $19200000000.00

Price 3-year low

$0.12
TNXP price is currently >+9900.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$101.09M
TNXP market capitalization is $101.09 million

Market cap 3-year change

-7.63%
TNXP market capitalization is down -7.63% over the past 3 years

Market cap All-time high

$2.16B
TNXP market capitalization is currently -95.31% below its historical high of $2.16 billion

Market cap sector rank

48.56%
TNXP market capitalization is higher than 48.56% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+21421.4%
TNXP shares outstanding is up +21421.4% year-on-year

Shares Outstanding 3-Year Change

+714888.89%
TNXP shares outstanding is up +714888.89% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.43
TNXP beta is 0.43

200-day SMA

$26.38
TNXP price is currently -40.45% below its 200-day simple moving average

50-day SMA

$15.14
TNXP price is currently +3.76% above its 50-day simple moving average

RSI

44.80
TNXP 14-day relative strength index is 44.80

Volume

0.21
TNXP 30-day relative volume is 0.21

ATR

$2.54
TNXP average true range is $2.54

10-day Historical Volatility

132.65%
TNXP 10-day historical volatility is 132.65%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$10.09M
TNXP annual revenue is $10.09 million

Revenue Analysts estimate

$11.10M
TNXP annual revenue is currently -9.06% lower than the consensus analysts' forecast

Revenue 1-year change

+29.94%
TNXP annual revenue is up +29.94% year-on-year

Revenue Sector rank

28.25%
TNXP annual revenue is higher than 28.25% of companies in Healthcare sector

EPS

EPS

-$176.60
TNXP annual earnings per share is -$176.60

EPS Analysts estimate

-$11.89
TNXP annual earnings per share is currently +1385.28% higher than the consensus analysts' forecast

EPS 1-year change

+98.8%
TNXP annual earnings per share is up +98.8% year-on-year

EPS Sector rank

1.24%
TNXP annual earnings per share is higher than 1.24% of companies in Healthcare sector

Profit

Gross profit

$2.33M
TNXP annual gross profit is $2.33 million

Gross margin

23.07%
TNXP annual gross profit margin is 23.07%

Operating profit

-$75.15M
TNXP annual operating income is -$75.15 million

Operating margin

-744.50%
TNXP annual operating profit margin is -744.50%

Net income

-$130.04M
TNXP annual net profit is -$130.04 million

Net margin

-1288.25%
TNXP annual net profit margin is -1288.25%

Expenses

Total expenses

$85.24M
TNXP annual total expenses is $85.24 million

Operating expenses

$77.48M
TNXP annual total operating expenses is $77.48 million

Cost of goods sold

$7.76M
TNXP annual cost of goods sold is $7.76 million

Selling, general & administrative expenses

$40.10M
TNXP annual SGA is $40.10 million

Depreciation and amortization

$3.42M
TNXP annual depreciation & amortization is $3.42 million

Interest expense

-
TNXP annual interest expense value is unknown

Income tax

-
TNXP annual income tax value is unknown

EBIT & EBITDA

EBIT

-$75.15M
TNXP annual earnings before interest & taxes is -$75.15 million

EBITDA

-$71.73M
TNXP annual EBITDA is -$71.73 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$162.89M
TNXP annual total assets is $162.89 million

Non current assets

$43.89M
TNXP annual long term assets is $43.89 million

Current assets

$119.00M
TNXP annual total current assets is $119.00 million

Cash and cash equivalents

$98.78M
TNXP annual cash & cash equivalents is $98.78 million

Accounts receivable

$3.68M
TNXP annual accounts receivable is $3.68 million

Inventory

$8.41M
TNXP annual inventory is $8.41 million

Liabilities

Total liabilities

$23.33M
TNXP annual total liabilities is $23.33 million

Long term liabilities

$5.03M
TNXP annual total long term liabilities is $5.03 million

Current liabilities

$18.31M
TNXP annual total current liabilities is $18.31 million

Accounts payable

$4.55M
TNXP annual accounts payable is $4.55 million

Debt

Total debt

$8.12M
TNXP annual total debt is $8.12 million

Total debt 1-year change

-17.26%
TNXP annual total debt is down -17.26% year-on-year

Long term debt

$5.03M
TNXP annual long term debt is $5.03 million

Short term debt

$3.09M
TNXP annual short term debt is $3.09 million

Equity & Capital

Shareholders equity

$139.56M
TNXP annual stockholders equity is $139.56 million

Book value

$139.56M
TNXP annual book value is $139.56 million

Retained earnings

-$730.69M
TNXP annual retained earnings is -$730.69 million

Working capital

$100.69M
TNXP annual working capital is $100.69 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$60.92M
TNXP annual cash flow from operations is -$60.92 million

Cash from operations 1-year change

+40.27%
TNXP annual cash flow from operations is up +40.27% year-on-year

Cash from investing

-$120.00K
TNXP annual cash flow from investing activities is -$120.00 thousand

Cash from investing 1-year change

+99.59%
TNXP annual cash flow from investing activities is up +99.59% year-on-year

Cash from financing

$134.87M
TNXP annual cash flow from financing activities is $134.87 million

Cash from financing 1-year change

+269.34%
TNXP annual cash flow from financing activities is up +269.34% year-on-year

CAPEX

CAPEX

$120.00K
TNXP annual capital expenditures is $120.00 thousand

CAPEX 1-year change

-98.48%
TNXP annual capital expenditures is down -98.48% year-on-year

Free Cash Flow

Free cash flow

-$61.05M
TNXP annual free cash flow is -$61.05 million

Free cash flow 1-year change

+44.45%
TNXP annual free cash flow is up +44.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

23.07%
TNXP annual gross profit margin is 23.07%

Operating margin

-744.50%
TNXP annual operating profit margin is -744.50%

Net margin

-1288.25%
TNXP annual net profit margin is -1288.25%

ROA & ROE

ROA

-81.95%
TNXP annual return on assets is -81.95%

ROE

-106.12%
TNXP annual return on equity is -106.12%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TNXP price to earnings ratio value is unknown

PE ratio Sector rank

-
TNXP price to earnings ratio is unknown

PB Ratio

PB ratio

0.72
TNXP price to book ratio is 0.72

PB ratio Sector rank

37.35%
TNXP price to book ratio is higher than 37.35% of companies in Healthcare sector

PS Ratio

PS ratio

10.02
TNXP price to sales ratio is 10.02

PS ratio Sector rank

78.95%
TNXP price to sales ratio is higher than 78.95% of companies in Healthcare sector

Enterprise value

Enterprise value

$10.44M
TNXP enterprise value is $10.44 million

Enterprise value Sector rank

25.12%
TNXP enterprise value is higher than 25.12% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.15
TNXP EV/EBITDA is -0.15

EV/EBITDA Sector rank

59.97%
TNXP EV/EBITDA is higher than 59.97% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.50
TNXP annual current ratio is 6.50

Quick ratio

6.04
TNXP annual quick ratio is 6.04

Leverage

Debt to equity

0.05
TNXP annual debt to equity ratio is 0.05

Interest coverage ratio

-
TNXP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

5
TNXP piotroski f-score is 5

Altman Z-Score

-4.40
TNXP altman z-score is -4.40

Analyst ratings

Recent major analysts updates

Mar 20, 25 Noble Capital Markets
Outperform
Jul 22, 24 Alliance Global Partners
Buy
Feb 28, 24 Dawson James
Buy
Aug 1, 23 Alliance Global Partners
Buy
Jun 2, 23 Alliance Global Partners
Buy
Jan 12, 23 Alliance Global Partners
Buy
Apr 18, 22 Noble Capital Markets
Outperform
Aug 31, 21 Alliance Global Partners
Buy
Aug 11, 21 Alliance Global Partners
Buy
Feb 25, 21 Alliance Global Partners
Buy

Institutional Ownership

Similar stocks

SNTI logo
Senti Biosciences (SNTI)
TIL logo
Instil Bio (TIL)
PROK logo
ProKidney (PROK)
AIRS logo
AirSculpt Technologies (AIRS)
INFU logo
InfuSystem Holdings (INFU)
Genelux (GNLX)
Anteris Technologies Global (AVR)
RPID logo
Rapid Micro Biosystems (RPID)
BTMD logo
biote (BTMD)
  • What is the ticker symbol for Tonix Pharmaceuticals Holding?
  • Does Tonix Pharmaceuticals Holding pay dividends?
  • What sector is Tonix Pharmaceuticals Holding in?
  • What industry is Tonix Pharmaceuticals Holding in?
  • What country is Tonix Pharmaceuticals Holding based in?
  • When did Tonix Pharmaceuticals Holding go public?
  • Is Tonix Pharmaceuticals Holding in the S&P 500?
  • Is Tonix Pharmaceuticals Holding in the NASDAQ 100?
  • Is Tonix Pharmaceuticals Holding in the Dow Jones?
  • When was Tonix Pharmaceuticals Holding's last earnings report?
  • When does Tonix Pharmaceuticals Holding report earnings?
  • Should I buy Tonix Pharmaceuticals Holding stock now?

What is the ticker symbol for Tonix Pharmaceuticals Holding?

The ticker symbol for Tonix Pharmaceuticals Holding is NASDAQ:TNXP

Does Tonix Pharmaceuticals Holding pay dividends?

No, Tonix Pharmaceuticals Holding does not pay dividends

What sector is Tonix Pharmaceuticals Holding in?

Tonix Pharmaceuticals Holding is in the Healthcare sector

What industry is Tonix Pharmaceuticals Holding in?

Tonix Pharmaceuticals Holding is in the Biotechnology industry

What country is Tonix Pharmaceuticals Holding based in?

Tonix Pharmaceuticals Holding is headquartered in United States

When did Tonix Pharmaceuticals Holding go public?

Tonix Pharmaceuticals Holding's initial public offering (IPO) was on May 10, 2012

Is Tonix Pharmaceuticals Holding in the S&P 500?

No, Tonix Pharmaceuticals Holding is not included in the S&P 500 index

Is Tonix Pharmaceuticals Holding in the NASDAQ 100?

No, Tonix Pharmaceuticals Holding is not included in the NASDAQ 100 index

Is Tonix Pharmaceuticals Holding in the Dow Jones?

No, Tonix Pharmaceuticals Holding is not included in the Dow Jones index

When was Tonix Pharmaceuticals Holding's last earnings report?

Tonix Pharmaceuticals Holding's most recent earnings report was on Mar 18, 2025

When does Tonix Pharmaceuticals Holding report earnings?

The next expected earnings date for Tonix Pharmaceuticals Holding is May 13, 2025

Should I buy Tonix Pharmaceuticals Holding stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page